Ceretas Limited (ASX:CTS)

Market Cap	64.95M
Revenue (ttm)	1.24M
Net Income	-1.63M
EPS	-0.05
Shares Out	71.38M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,261
Open	0.9100
Previous Close	0.9100
Day's Range	0.9100 - 0.9150
52-Week Range	0.2500 - 1.1100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Ceretas

Ceretas Limited, a medical technology company that develops portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia. The company’s technology operates through two primary mechanisms, including neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits; and BBBO, which temporarily and reversibly opens the blood-brain barrier using ultrasound combined with circulating microbubbles that facilitates brain's natural clearance...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2024
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CTS

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error